Recombinant human endostatin adenovirus - Chengdu Shi Endor Biological Engineering TechnologyAlternative Names: EDS-01
Latest Information Update: 08 Jan 2016
At a glance
- Originator Chengdu Shi Endor Biological Engineering Technology
- Class Antineoplastics; Eye disorder therapies; Gene therapies
- Mechanism of Action Angiogenesis inhibitors; Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Head and neck cancer